REQUEST A DEMO
Total
USD $0.00
Search more companies

Amivox Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: All Other Miscellaneous Schools and Instruction | Offices of Physicians
Full name: Amivox Sp. z o.o. Profile Updated: March 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Amivox Sp. z o.o. is based in Poland, with the head office in Warsaw. It operates in the Pharmacies and Drug Stores industry. It was established on October 12, 2021. The latest financial highlights indicate a net sales revenue increase of 31.24% in 2024. There was a total growth of 106.22% in Amivox Sp. z o.o.’s total assets over the same period. The net profit margin of Amivox Sp. z o.o. increased by 0.5% in 2024.

Headquarters
Ul. Aleja Niepodleglosci 121/123
Warsaw; Mazowieckie; Postal Code: 02-588

Contact Details: Purchase the Amivox Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Amivox Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Amivox Sp. z o.o. report to view the information.
Incorporation Date:
October 12, 2021
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Amivox Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
31.24%
Total operating revenue
31.25%
Operating profit (EBIT)
39.34%
EBITDA
46.78%
Net Profit (Loss) for the Period
35.28%
Total Assets
106.22%
Total Equity
167.11%
Operating Profit Margin (ROS)
1%
Net Profit Margin
0.5%
Return on Equity (ROE)
-60.97%
Quick Ratio
0.87%
Cash Ratio
0.9%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?